Counting the carbon cost of heparin: an evolving tragedy of the commons?

Fan, Bingwen Eugene; Favaloro, Emmanuel J

Fan, Bingwen Eugene; Favaloro, Emmanuel J.

Fan BE; Department of Haematology, Tan Tock Seng Hospital, 308433 Singapore; Department of Laboratory Medicine, Khoo Teck Puat Hospital, Singapore; Lee Kong Chian School of Medicine, Singapore; Yong Loo Lin School of Medicine, Singapore. Electronic address: bingwen_eugene_fan@ttsh.com.sg.
Favaloro EJ; Faculty of Science and Health, Charles Sturt University, Wagga Wagga, NSW, Australia; Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Sydney, NSW, Australia; Sydney Centres for Thrombosis and Haemostasis, Sydney, NSW, Australia.

Lancet Haematol ; 9(7): e469-e471, 2022 07.

Article in English | MEDLINE | ID: covidwho-1927001

Subject(s)

Carbon; Heparin; Heparin/therapeutic use; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Carbon / Heparin Limits: Humans Language: English Journal: Lancet Haematol Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google